Validation of a New Automatic Bi-level Algorithm in the Treatment of Sleep-disordered Breathing
1 other identifier
interventional
150
1 country
1
Brief Summary
Between 2%-4% of adult population suffers from obstructive sleep apnea (OSAS)(1), which is characterized by obstructive snoring, repetitive apnea and hypopnea in sleep, repetitive cyclic oxygen saturation, as a result from sleep fragmentation related to the arousals in sleeping profile and clinical consequences like day drowsiness, neuropsychological deficits, raised danger of accidents and cardiovascular disease. (1-6). The therapy of choice is the application of nasal continuous positive airway pressure (CPAP) (7-9). Increasing relevance obtain the combined sleep-related breathing disturbances, where the patient shows an obstructive sleep apnea syndrome and some central breathing disturbances in the polysomnography at night. Those patients frequently present with cardiovascular diseases. These combined night breathing disturbances are frequently insufficient to be mitigated exclusively with a CPAP therapy. Some modifications of nCPAP therapy were developed in order to optimize the therapy-compliance and the effectiveness of the therapy. Bi-level-CPAP-devices produce two pressure levels: one for inspiration and another for expiration, so that the patients are able expire against a constant low pressure. An increase in the use of this application in comparison between the conventional or the automatic CPAP therapy could not be proved in early studies. (12, 13) The principle of the automatic nCPAP therapy is to recognize the patient's current need of pressure and to alter the pressure within a set range by applying different algorithms. Some studies have shown that this therapy increased compliance and comfort (14-16), while other studies could not confirm these results. (17, 18) The result of the current study should prove if the treatment of a new algorithm therapy based on an automatic bi-level-system for patients with sleep-related respiratory disorders is as effectively and subjective more comfortable as the conventional CPAP therapy. Patients with a particularly high need of pressure should experience a clear expiratory pressure relief and a higher comfort. Therefore a better compliance is to expect. In the same way patients with additional central respiratory disturbances should obtain a benefit from the bi-level modus. This new treatment would help particularly such "critical patients", who are not responding well to the CPAP therapy or find it uncomfortable.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2008
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2008
CompletedFirst Submitted
Initial submission to the registry
May 28, 2009
CompletedFirst Posted
Study publicly available on registry
May 29, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2011
CompletedAugust 9, 2011
August 1, 2011
2.8 years
May 28, 2009
August 8, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Obstructive and central apnea-hypopnea-Index.
day one and two of the study
Secondary Outcomes (1)
Total apnea-hypopnea-index, minimum and middle oxygen saturation, subjective satisfaction with the therapy (questionnaire).
day one and two of the study
Study Arms (2)
CPAP before Bi-Level-APAP
EXPERIMENTALreceiving CPAP treatment during the first night and then Bi-level-APAP treatment during second night
Bi-Level-APAP before CPAP
EXPERIMENTALreceiving Bi-level-APAP treatment during the first night and then CPAP treatment during the second night
Interventions
CPAP treatment during the first night and then Bi-level-APAP treatment during second night
Bi-level-APAP treatment during the first night and then CPAP treatment during the second night
Eligibility Criteria
You may qualify if:
- Men and women \> 18 years.
- Newly diagnosed of sleep-apnea-syndrome, AHI\> 5 per hour associated with the usual manifestation of this syndrome.
- Declaration of consent.
You may not qualify if:
- Absence of declaration of consent.
- Other relevant sleep disorders like insomnia, restless legs, parasomnia
- Heart failure NYHA-CLASS III- IV.
- Myocardial infarction or unstable angina pectoris or cardiac surgery in within the last three months.
- Apnea-hypopnea-index \< 5 per hour.
- Pregnancy.
- Malign diseases.
- Serious chronic oxygen-requiring pulmonary illness.
- Age under 18 years.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wissenschaftliches Institut Bethanien e.V.
Solingen, North Rhine-Westphalia, 42699, Germany
Related Publications (7)
Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Nieto FJ, O'Connor GT, Boland LL, Schwartz JE, Samet JM. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001 Jan;163(1):19-25. doi: 10.1164/ajrccm.163.1.2001008.
PMID: 11208620BACKGROUNDYoung T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993 Apr 29;328(17):1230-5. doi: 10.1056/NEJM199304293281704.
PMID: 8464434BACKGROUNDFinn L, Young T, Palta M, Fryback DG. Sleep-disordered breathing and self-reported general health status in the Wisconsin Sleep Cohort Study. Sleep. 1998 Nov 1;21(7):701-6.
PMID: 11286346BACKGROUNDEngleman HM, Kingshott RN, Martin SE, Douglas NJ. Cognitive function in the sleep apnea/hypopnea syndrome (SAHS). Sleep. 2000 Jun 15;23 Suppl 4:S102-8.
PMID: 10893080BACKGROUNDGeorge CF. Sleep. 5: Driving and automobile crashes in patients with obstructive sleep apnoea/hypopnoea syndrome. Thorax. 2004 Sep;59(9):804-7. doi: 10.1136/thx.2003.007187.
PMID: 15333860BACKGROUNDRanderath WJ, Schraeder O, Galetke W, Feldmeyer F, Ruhle KH. Autoadjusting CPAP therapy based on impedance efficacy, compliance and acceptance. Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):652-7. doi: 10.1164/ajrccm.163.3.2006168.
PMID: 11254519BACKGROUNDRanderath WJ, Galetke W, Ruhle KH. Auto-adjusting CPAP based on impedance versus bilevel pressure in difficult-to-treat sleep apnea syndrome: a prospective randomized crossover study. Med Sci Monit. 2003 Aug;9(8):CR353-8.
PMID: 12942031BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Wolfgang Galetke, PD Dr.
- STUDY DIRECTOR
Winfried J. Randerath, Prof. Dr.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 28, 2009
First Posted
May 29, 2009
Study Start
June 1, 2008
Primary Completion
April 1, 2011
Study Completion
April 1, 2011
Last Updated
August 9, 2011
Record last verified: 2011-08